Cite
Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing
MLA
Yi-Yen Lee, et al. “Optimizing Tumor-Associated Antigen-Stimulated Autologous Dendritic Cell and Cytokine-Induced Killer Cell Coculture to Enhance Cytotoxicity for Cancer Immunotherapy in Manufacturing.” BMC Immunology, vol. 24, no. 1, June 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12865-023-00552-5.
APA
Yi-Yen Lee, Shao-Ciao Luo, Chung-Hsin Lee, Chien-Lun Tang, Chiung-Chyi Shen, Wen-Yu Cheng, Yi-Chin Yang, Meng-Yin Yang, & Chun-Ming Yen. (2023). Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing. BMC Immunology, 24(1), 1–11. https://doi.org/10.1186/s12865-023-00552-5
Chicago
Yi-Yen Lee, Shao-Ciao Luo, Chung-Hsin Lee, Chien-Lun Tang, Chiung-Chyi Shen, Wen-Yu Cheng, Yi-Chin Yang, Meng-Yin Yang, and Chun-Ming Yen. 2023. “Optimizing Tumor-Associated Antigen-Stimulated Autologous Dendritic Cell and Cytokine-Induced Killer Cell Coculture to Enhance Cytotoxicity for Cancer Immunotherapy in Manufacturing.” BMC Immunology 24 (1): 1–11. doi:10.1186/s12865-023-00552-5.